The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3207-3214

  Baskar, John F ^a   Smith, Patricia P ^a   Nilaver, Gajanan ^b   Jupp, Ray A ^a,f   Hoffmann, Stefan ^a   Peffer, Nancy J ^a   Tenney, Daniel J ^c   Colberg Poley, Anamaris M ^d   Ghazal, Peter ^e   Nelson, Jay A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

EID: 9244230548     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3207-3214.1996     Document Type: Article

References (59)

1. Angulo, A., C. Suto, M. F. Buehm, R. A. Heyman, and P. Ghazal. 1995. Retinoid activation of retinoic acid receptors but not retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69:3831-3837.
2. Baskar, J. F., P. Smith, G. Ciment, S. Hoffmann, C. Tucker, D. J. Tenney, A. M. Colberg-Poley, J. A. Nelson, and P. Ghazal. 1996. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J. Virol. 70:3215-3226
3. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstien, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate-early gene of human cytomegalovirus. Cell 41:521-530.
4. Cameron, J., R. J. Rigby, A. G. van Deth, and J. J. B. Petrie. 1982. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. Clin. Nephrol. 18:321-325.
5. Chang, Y. N., S. Crawford, S. Stall, D. R. Rawlins, K. T. Jeang, and G. S. Hayward. 1990. The palindromic series I repeats in the simian cytomegalovirus major immediate-early promoter behave as both strong basal enhancers and cyclic AMP response elements. J Virol. 64:264-277.
6. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchinson III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
7. DeMarchi, J. M., C A. Schmidt and A. S. Kaplan. 1980. Pattern of transcription of human cytomegalovirus in permissively infected cells. J. Virol. 35:277-286.
8. Diethelm, A. G., I. Gore, L. T. Ch'ien, W. A. Sterling, and J. M. Morgan. 1976 Gastrointestinal hemorrhage secondary to cytomegalovirus after renal transplantation. A case report and review of the problem. Am. J. Surg 131:371-374.
9. Farber, S., and S. G. Wolback. 1932. Intranuclear and cytoplasmic inclusions ("protozoan-like bodies") in the salivary glands and other organs of infants. Am. J. Pathol. 8:123-135
10. Furth, P. A., L. Hennighausen, C. Baker, B. Beatty, and R. Woychick. 1991. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19:6205-6208
11. Ghazal, P., C. DeMattei, E. Giulietti, S. A. Kliewer, K. Umesono, and R. M. Evans. 1992. Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells Proc. Natl. Acad. Sci. USA 89:7630-7634.
12. Ghazal, P., H. Lubon, and L. Henninghausen. 1988. Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate-early gene. J. Virol. 62:1076-1079.
13. Ghazal, P., H. Lubon, and L. Henninghausen. 1988 Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol. Cell. Biol. 8:1809-1811.
14. Ghazal, P., and J. A. Nelson. 1993. Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis, p. 360-383. In Y. Becker, G. Darai, and E.-S. Huang (ed.). Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, Berlin.
15. Gnann, J. W., Jr., J. Ahlmen, C. Svalander, L. Olding, M. B. A. Oldstone, and J. A. Nelson. 1988. Inflammatory cells in transplant kidneys are infected by human cytomegalovirus. Am. J. Pathol 132:239-248.
16. Haymaker, W., B. R. Girdany, J. Stephens, R. D. Lillie, and G. H. Fetterman. 1954. Cerebral involvement with advanced penventricular calcification in generalized cytomegalic inclusion disease in the neuborn J. Neuropathol. Exp. Neurol. 13:562-586.
17. Hogan, B., F. Constatini, and E. Lacy. 1986. Manipulating the mouse embryo. A laboratory manual, p. 153-182. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
18. Huang, E.-S., M. G. Davis, J. F. Baskar, and S. M. Huong. 1985. Molecular epidemiology and oncogenicity of human cytomelovirus, p. 323-344. In C. C. Harris (ed.). Biochemical and molecular epidemiology of cancer. Abbott-UCLA Symposium. Alan R. Liss, Inc., New York.
19. Hunninghake, G. W., M. M. Monick, B. Liu, and M. F. Stinski. 1989. The promoter regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J. Virol. 63:3026-3033.
20. Jenson, A. B., H. S. Rosenberg, and A. L. Notkins. 1980. Pancreatic islet cell damage in children with fatal viral infections. Lancet ii:354-358.
21. Kennedy, P. G., D. A. Newsome, J. Hess, O. Narayan, D. L. Suresch, W. R. Green, and R. C. Gallo. 1986. Cytomegalovirus but not HTLV-III detected by in situ hybridization in retinal lesions in patients with AIDS. Br. Med. J. 293:162-164.
22. Klemola, E., R. Stenstrom, and R. von Essen. 1972. Pneumonia as a clinical manifestation of cytomegalovirus infection in previously healthy adults. Scand. J. Infect. Dis. 4:7-10.
23. Koedood, M., A. Fichtel, P. Meier, and P. J. Mitchell. 1995. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69:2194-2207.
24. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91:11879-11883.
25. Kothari, S., J. Baille, J. G. Sissons, and J. H. Sinclair. 1991. The 21bp repeat element of the human cytomegalovirus major immediate-early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res. 19:1767-1771.
26. Lee, J. Y.-Y. 1989. Cytomegalovirus infection involving skin in immunocompromised hosts. A clinicopathologic study. Am. J. Pathol. 92:96-100.
27. Liu, B., and M. F. Stinski. 1992. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
28. LiVolsi, V. A., and M. J. Merino. 1979. Cytomegalovirus infection of ovarian thecoma. Arch. Pathol. Lab Med. 103:653-654.
29. Maciejewski, J. P., E. E. Brenning, R. E. Donahue, E. S. Mocarski, R. E. Young, and S. C. St. Jeor. 1992 Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
30. Melnick, J. L., E. Adam, and M. E. Debakey. 1993. Cytomegalovirus and atherosclerosis Eur. Heart J. 14(Suppl.):30-38.
31. Morgello, S., E. S. Cho, S. Nielsen, O. Devinsky, and C. K. Petito. 1987. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome Hum. Pathol. 18:289-297.
32. Mueller, N., J. Hinkula, and B. Wahren. 1988 Elevated antibody titers against cytomegalovirus among patients with testicular cancer. Int. J. Cancer 41:399-403
33. Nelson, J. A., J. W. Gnann, Jr., and P. Ghazal. 1990. Regulation and tissue-specific expression of human cytomegalovirus. Curr. Top. Microbiol. Immunol. 154:75-100.
34. Nelson, J. A., and M. Groudine. 1986. Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol Cell Biol. 6:452-461.
35. Nelson, J. A., C. Reynolds-Kohler, M. B. A. Oldstone, and C. A. Wiley. 1988. HIV and CMV coinfect brain cells in patients with AIDS. Virology 165:286-290.
36. Nelson, J. A., C. Reynolds-Kohler, and B. Smith. 1987. Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene. Mol Cell. Biol. 7:4125-4129.
37. Nilaver, G., and G. P. Kozlowski. 1989. Comparison of the PAP and ABC immunocytochemical techniques, p. 199-215. In G. R. Bullock and P. Petrusz (ed.). Techniques in immunocytochemistry, vol. 4. Academic Press, New York.
38. Nilaver, G., L. L. Muldoon, R. A. Kroll, M. A. Pagel, X. O. Breakefield, B. L. Davidson, and E. A. Neuwelt. 1995. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad. Sci. USA 92:9829-9833.
39. Niller, H. H., and L. Hennighausen. 1990. Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP. J. Virol. 64:2388-2391.
40. Roque, A. L., N. A. Jafarey, and P. Coulter. 1965. A stain for the histochemical demonstration of nucleic acids. Exptl. Mol. Pathol. 4:266-274.
41. Sambucetti, L. C., J. M. Cherrington, G. W. G. Wilkinson, and E. S. Mocarski. 1989. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258.
42. Sanes, J. R., L. R. Rubenstein, and J. F. Nicolas. 1986. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:3133-3142.
43. Schmidt, E. V., G. Christoph, R. Zeller, and P. Leder. 1990. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell. Biol. 10:4406-4411.
44. Shelbourn, S. L., S. K. Kothari, J. G. Sissons, and J. H. Sinclair. 1989. Repression of human cytomegalovirus gene expression associated with a novel immediate-early regulatory region binding factor. Nucleic Acids Res. 17:9165-9171.
45. Shorr, R. I., W. L. Longo, T. D. Oberley, M. J. Bozdech, and D. L. Walker. 1987. Cytomegalovirus-associated tubulointerstitial nephritis in an allogenic bone marrow transplant recipient. Ann Intern. Med. 107:351-352.
46. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
47. Speir, E., R. Modali, E.-S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
48. Stamminger, T., H. Fickenscher, and B. Fleckenstein. 1990. Cell type-specific induction of the major immediate-early enhancer of human cytomegalovirus by cyclic AMP. J. Gen. Virol. 71:105-113.
49. Stenberg, R. M., A. S. Depto, J. Fortney, and J. A. Nelson. 1989. Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63:2699-2708.
50. Stenberg, R. M., D. R. Thomsen, and M. F. Stinski. 1984. Structural analysis of the major immediate-early gene of human cytomegalovirus. J. Virol. 49:190-199.
51. Stenberg, R. M., P. R. Witte, and M. F. Stinski. 1985. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region two and evidence for a common initiation site within immediate-early region one. J. Virol. 58:665-675.
52. Sterner, G., B. O. Agell, B. Sahren, and A. Espmark. 1970. Acquired cytomegalovirus infection in older children and adults. Scand. J. Infect. Dis 2:95-103.
53. Subietas, A., L. J. Deppisch, and J. Astarloa. 1977. Cytomegalovirus oophoritis: ovarian cortical necrosis. Hum. Pathol 8:285-292.
54. Teixidor, H. S., C. L. Honig, E. Norsoph, S. Albert, J. A. Mouradian, and J. P. Whalen. 1987. Cytomegalovirus infection of the alimentary canal: radiologic findings with pathologic correlation. Radiology 163:317-323
55. Thomsen, D. R., R. M. Stenberg, W. F. Goins, and M. F. Stinski. 1984. Promoter-regulatory region of the major immediate-early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 81:659-663
56. Ward, P. H., J. R. Lindsay, and N. E. Warner. 1965. Cytomegalic inclusion disease affecting the temporal bone. Laryngoscope 75:628-638.
57. Wathen, M. W., and M. F. Stinsld. 1982. Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate-early, early, and late times after infection. J. Virol. 41:462-477
58. Wiley, C. A., and J. A. Nelson. 1988. Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am. J. Pathol. 133:73-51
59. Wiley, C. A., R. D. Schrier, F. J. Denaro, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. 1986. Localization of cytomegalovirus proteins and genome during fulminate central nervous system infection in an AIDS patient. J. Neuropathol. Exp. Neurol. 45:127-139.